Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis
Clinical trial NCT03824405 · COMPLETED
Trial details
- NCT number
- NCT03824405
- Sponsor
- Botanix Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-04
- Primary completion
- 2020-01-27
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.